S. Ohlson

Strength of weakness in molecular interactions: toward transient medicines in drug discovery.

Biological systems are governed by a myriad of molecular interactions, many of which remain poorly recognized. Growing evidence suggests that transient interactions (Kdiss >1 µM) dominate the interactome and are crucial for dynamic molecular networks. By contrast, drug discovery has largely focused on high-affinity com...